We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Cognition Holdings PLC | AQSE:COG.GB | Aquis Stock Exchange | Ordinary Share | GB00B8DV9647 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 54.50 | 51.00 | 58.00 | 54.50 | 54.50 | 54.50 | 0.00 | 07:01:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCOG
RNS Number : 2393C
Cambridge Cognition Holdings PLC
24 June 2016
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Result of AGM
The neuroscience company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets products and near patient technologies for cognitive assessment in clinical trials and healthcare applications held its Annual General Meeting yesterday at 11.00am at the registered office of the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. All resolutions were duly passed.
At the meeting Steven Powell, Chief Executive Officer, provided shareholders with the following update:
"As we outlined in our Preliminary Results statement, we intend to accelerate revenue growth in both the academic research and pharmaceutical clinical trials business this year. We plan to achieve this through;
1). Investment in commercial infrastructure,
2). The launch of our online and wearable product platforms and
3). The introduction of partner products to maximise our sales channels exemplified by the recent announcements relating to the AnthroTronix DANA product and the MANUS pen for Parkinson's assessment.
We have made significant progress in the first half of 2016 towards implementation of our plan and we remain confident in the outlook for the year."
Enquiries:
Cambridge Cognition www.cambridgecognition.com Holdings plc Steven Powell, Chief Tel: 01223 810 Executive Officer 700 Nick Walters, Chief Financial Officer finnCap Ltd (Nomad Tel: 020 7220 0500 & Joint Broker) Geoff Nash / Simon (Corporate Finance) Hicks Alice Lane (Corporate Broking) Hybridan LLP (Joint Tel: 020 3764 2341 Broker) Claire Noyce (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGAKQDNDBKDDAB
(END) Dow Jones Newswires
June 24, 2016 07:33 ET (11:33 GMT)
1 Year Cambridge Cognition Chart |
1 Month Cambridge Cognition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions